We do research for your health.We do research for your health.
Cell culture

Complete, ready-to-use media with long-term stability for cell culture of special cells.

Ready-to-use media

Ready-to-use media formulated specifically for growth of interleukin-2 dependent cells.

For special applications

Our products are developed using a stress test and optimized for special applications.


Fastidious cells thrive in our special CTLL-2 ready-to-use medium.


About 40 years ago a growth hormone for immune cells was discovered that these cells produce themselves. In cell culture in the laboratory immune cells, the body’s own police, began to proliferate. And this growth factor could do much more. Initially it was named T cell growth factor, but immune cells not only increased in number under its influence they also became highly effective killer cells against cancer and virus cells. T cell growth factor was renamed interleukin-2.

Learn more


Interleukin-2 is a natural immune hormone and the basis for our modern medicines, vaccines and growth factors. We develop products focusing on immune defense. On contact with interleukin-2, immune cells start to multiply, recognize cancer and virus cells and act as “natural killer cells” to destroy these harmful cells.

Learn more


Immunservice supports your research and development with quality products suitable specifically for special applications in the interleukin-2 area. We support you with services in the interleukin-2 area, including bioactivity measurements of interleukin-2, and would be happy to advise you. Immunservice develops its own broad range of innovative interleukin-2-based medicines for market approval.

Learn more

Human Immunotherapy
  • Lung metastases (inhalation interleukin-2)
  • Bladder cancer (instillation into the bladder)
  • Virus-induced locally aggressive tumours (injection into viral tumours)
  • Obesity immunotherapy
  • Immunotherapy of nicotine addiction
Human Cell Therapy
  • Adoptive cell therapies for viral diseases, cancers and immune system failure
  • CAR T cells
  • Cytokine-induced killer cells (CIK cell therapy)
  • Natural killer cell therapy
  • T Regulatory cell therapy
  • Cytotoxic cell therapy
  • Dendritic cell therapy
Animal Immunotherapy
  • Local injection therapy for papillomaviruses in dogs, cats and horses (“sarcoids”)
  • Aggressive inoperable tumours
  • Therapeutic immunization in immunodeficiency due to cancer or infections
  • Interleukin-2 based vaccine boosters (adjuvants) for weak vaccine antigens
  • Cell culture of immune cells (including lymphocytes, monocytes and natural killer cells)
  • Interleukin-2 complete medium I2Cult for CTLL-2
  • Interleukin-2 complete medium I2Cult for immune cells
  • Interleukin-2 growth factor
  • Proliferation measurements
  • Service for subcontractor performance of proliferation tests (CTLL-2 proliferation, etc.)